MULTIOMICS AND THERAPY STACKING: Personalized Cancer Care | Ep 13

preview_player
Показать описание
Description: Personalized medicine is the future available today. With the integration of multiomics in the personalized treatment protocol not only of cancer patients but any chronic disease, the individual as a whole is being considered and the root cause is addressed through personalized and individualized care.

Targeted therapies, such as Osimertinib and Ribociclib, mark a significant advancement in cancer treatment. Osimertinib destructively targets abnormal proteins found on some cancers, while Ribociclib counteracts abnormal growth hormones in breast cancer, being used earlier in the treatment process to enhance survival rates. Employing these therapies proactively before recurrences can directly improve patient survival outcomes, revolutionizing cancer treatment.

Dr. Nathan Goodyear was recently featured on Fox News and on this podcast he will comment on the findings of these new cancer pills.

*************

Рекомендации по теме